BMTCN EXAM PACKAGE DEAL GRADED A+

Which of the following is NOT an identified risk factor associated with infection? A. Personal history of infection B. Type of transplantation (autologous or allogeneic) C. Myeloablative transplant D. None of the above -Answer D. None of the above Clostridium difficile is not a common infection...

A patient with multiple myeloma is receiving high-dose melphalan. The nurse has the patient chew on ice during the infusion to reduce the risk of mucositis. This is an example of which of the following? A. A clinical trial B. Evidence-based practice C. Outcome identification D. Research - Answe...

T.R. is a 28-year-old woman with acute myeloid leukemia in her second complete remission who is admitted for a matched unrelated allogeneic stem cell transplantation. Her conditioning regimen is as follows: Myeloablation (busulfan/cyclophosphamide) and immunosuppression with tacrolimus and metho...

Transplant-related toxicity is a barrier that contributes to the under utilization for which of the following diseases? A. Non-Hodgkin lymphoma B. Acute myeloid leukemia C. Sickle cell disease D. Neuroblastoma - Answer C. Sickle cell disease Despite success of HSCT in sickle cell disease, barr...

Which of the following studies should be completed at regular intervals for a patient receiving long-term steroids? A. Positron emission tomography scan B. Magnetic resonance imaging C. Dual energy x-ray absorptiometry D. Computed tomography scan - Answer C. Dual energy x-ray absorptiometry Th...

Immunoglobulins are secreted by which type of cell? A. B-lymphocyte B. Megakaryocyte C. T-lymphocyte D. Natural killer - Answer A. B-lymphocyte B lymphocytes synthesize and secrete immunoglobulins. Which portion of the immunoglobulin activates the complement pathway? A. MHC Class I B. Fab C...